Long‐Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real‐World Clinical Practice: A 15‐Year Longitudinal Study

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Abdelrahman Khater, Marwa Al‐Badri, Tareq Salah, Shilton E. Dhaver, Karim Kibaa, Osama Hamdy
Formato: Artículo Open Access
Publicado: Wiley 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867017802163945472
author Abdelrahman Khater
Marwa Al‐Badri
Tareq Salah
Shilton E. Dhaver
Karim Kibaa
Osama Hamdy
author_facet Abdelrahman Khater
Marwa Al‐Badri
Tareq Salah
Shilton E. Dhaver
Karim Kibaa
Osama Hamdy
Abdelrahman Khater
Marwa Al‐Badri
Tareq Salah
Shilton E. Dhaver
Karim Kibaa
Osama Hamdy
collection Wiley Open Access
contents Long‐Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real‐World Clinical Practice: A 15‐Year Longitudinal Study Abdelrahman Khater Marwa Al‐Badri Tareq Salah Shilton E. Dhaver Karim Kibaa Osama Hamdy Journal of Diabetes ABSTRACT Introduction We previously demonstrated that achieving and maintaining ≥ 7% weight loss at 1 year in patients with diabetes (DM), through multidisciplinary intensive lifestyle intervention (ILI) in real‐world clinical practice, predicts improvement in cardiometabolic outcomes at 5 and 10 years. In this prospective follow‐up, we report 15‐year results. Methods We evaluated 122 patients with DM and obesity (mean age 53.2 ± 10.0 years, 68% females, 90.2% type 2 DM, mean DM duration 9.1 ± 8.6 years, mean BMI 38.4 ± 5.2 kg/m 2 ) who completed a 12‐week ILI program. The cohort achieved an average weight loss of 10.7 ± 4.6 kg (−9.6%, p  < 0.001) at 12 weeks and was divided into two groups at 1 year: group A, who maintained < 7% weight loss (47.5%) and group B, who maintained ≥ 7% weight loss (52.5%). Results At 15 years, the cohort maintained an average weight loss of 8.6 ± 11.9 kg (−7.6%, p  < 0.001). Group B demonstrated superior sustained weight loss (12.9 ± 12.0 kg, −11.0%) compared to group A (3.8 ± 10.0 kg, −4.0%) with p  < 0.001 between groups. A1C in group B improved from 7.3% ± 1.1% to 6.3% ± 0.8% at 12 weeks and remained at 7.3% ± 1.5% at 15 years, while group A's A1C increased from 6.7% ± 0.9% to 7.9% ± 1.8% ( p  = 0.04 between groups). Both groups maintained LDL‐ and HDL‐cholesterol improvements, but group A experienced significant worsening of serum triglycerides. Conclusions ILI in real‐world clinical practice that results in ≥ 7% weight loss at 1 year in patients with DM and obesity is associated with continued improvement in cardiometabolic outcomes at 15 years. 10.1111/1753-0407.70153 http://creativecommons.org/licenses/by/4.0/
doi_str_mv 10.1111/1753-0407.70153
format Artículo Open Access
id wiley_oa_10_1111_1753_0407_70153
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by/4.0/
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Long‐Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real‐World Clinical Practice: A 15‐Year Longitudinal Study
Abdelrahman Khater
Marwa Al‐Badri
Tareq Salah
Shilton E. Dhaver
Karim Kibaa
Osama Hamdy
Journal of Diabetes
Long‐Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real‐World Clinical Practice: A 15‐Year Longitudinal Study Abdelrahman Khater Marwa Al‐Badri Tareq Salah Shilton E. Dhaver Karim Kibaa Osama Hamdy Journal of Diabetes ABSTRACT Introduction We previously demonstrated that achieving and maintaining ≥ 7% weight loss at 1 year in patients with diabetes (DM), through multidisciplinary intensive lifestyle intervention (ILI) in real‐world clinical practice, predicts improvement in cardiometabolic outcomes at 5 and 10 years. In this prospective follow‐up, we report 15‐year results. Methods We evaluated 122 patients with DM and obesity (mean age 53.2 ± 10.0 years, 68% females, 90.2% type 2 DM, mean DM duration 9.1 ± 8.6 years, mean BMI 38.4 ± 5.2 kg/m 2 ) who completed a 12‐week ILI program. The cohort achieved an average weight loss of 10.7 ± 4.6 kg (−9.6%, p  < 0.001) at 12 weeks and was divided into two groups at 1 year: group A, who maintained < 7% weight loss (47.5%) and group B, who maintained ≥ 7% weight loss (52.5%). Results At 15 years, the cohort maintained an average weight loss of 8.6 ± 11.9 kg (−7.6%, p  < 0.001). Group B demonstrated superior sustained weight loss (12.9 ± 12.0 kg, −11.0%) compared to group A (3.8 ± 10.0 kg, −4.0%) with p  < 0.001 between groups. A1C in group B improved from 7.3% ± 1.1% to 6.3% ± 0.8% at 12 weeks and remained at 7.3% ± 1.5% at 15 years, while group A's A1C increased from 6.7% ± 0.9% to 7.9% ± 1.8% ( p  = 0.04 between groups). Both groups maintained LDL‐ and HDL‐cholesterol improvements, but group A experienced significant worsening of serum triglycerides. Conclusions ILI in real‐world clinical practice that results in ≥ 7% weight loss at 1 year in patients with DM and obesity is associated with continued improvement in cardiometabolic outcomes at 15 years. 10.1111/1753-0407.70153 http://creativecommons.org/licenses/by/4.0/
title Long‐Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real‐World Clinical Practice: A 15‐Year Longitudinal Study
topic Journal of Diabetes
url https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.70153